- Home
- IMNN vs AMZE Comparison
IMNN vs AMZE Comparison
Compare IMNN & AMZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMNN
- AMZE
- Stock Information
- Founded
- IMNN 1982
- AMZE 2019
- Country
- IMNN United States
- AMZE United States
- Employees
- IMNN N/A
- AMZE N/A
- Industry
- IMNN Biotechnology: Pharmaceutical Preparations
- AMZE Beverages (Production/Distribution)
- Sector
- IMNN Health Care
- AMZE Consumer Staples
- Exchange
- IMNN Nasdaq
- AMZE Nasdaq
- Market Cap
- IMNN 12.9M
- AMZE 12.3M
- IPO Year
- IMNN 1985
- AMZE 2021
- Fundamental
- Price
- IMNN $5.10
- AMZE N/A
- Analyst Decision
- IMNN Buy
- AMZE
- Analyst Count
- IMNN 2
- AMZE 0
- Target Price
- IMNN $182.61
- AMZE N/A
- AVG Volume (30 Days)
- IMNN 160.1K
- AMZE 151.3K
- Earning Date
- IMNN 11-06-2025
- AMZE 11-13-2025
- Dividend Yield
- IMNN N/A
- AMZE N/A
- EPS Growth
- IMNN N/A
- AMZE N/A
- EPS
- IMNN N/A
- AMZE N/A
- Revenue
- IMNN N/A
- AMZE $1,054,111.00
- Revenue This Year
- IMNN N/A
- AMZE $6,741.66
- Revenue Next Year
- IMNN N/A
- AMZE $100.61
- P/E Ratio
- IMNN N/A
- AMZE N/A
- Revenue Growth
- IMNN N/A
- AMZE N/A
- 52 Week Low
- IMNN $4.70
- AMZE $1.57
- 52 Week High
- IMNN $41.22
- AMZE $28.72
- Technical
- Relative Strength Index (RSI)
- IMNN 41.04
- AMZE 40.09
- Support Level
- IMNN $4.91
- AMZE $1.80
- Resistance Level
- IMNN $5.39
- AMZE $2.21
- Average True Range (ATR)
- IMNN 0.24
- AMZE 0.43
- MACD
- IMNN 0.00
- AMZE -0.01
- Stochastic Oscillator
- IMNN 26.51
- AMZE 20.33
About IMNN Imunon Inc.
Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective, and durable responses across various human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. Its clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer that has completed Phase II clinical studies. Additionally, the Company has entered a first-in-human study of its COVID-19 booster vaccine (IMNN-101).
About AMZE Amaze Holdings Inc. Common Stock
Amaze Holdings Inc is engaged in producer of low carb, low calorie, premium wines in the United States. The company offers bold, crisp, and creamy wines that embody health, warmth, and a deeper connection to wellness and an active lifestyle. The company currently sell seven proprietary varietals: Cabernet Sauvignon, Pinot Noir, Chardonnay, Sauvignon Blanc, Rose, Sparkling Rose, and a limited Reserve Napa Cabernet Sauvignon.